Cross-talk between constitutive and inducible NO synthase: An update

Antioxidants and Redox Signaling

Volumn 8, Issue 5-6, 2006, Pages 949-954

  Persichini, Tiziana ^a   Cantoni, Orazio ^b   Suzuki, Hisanori ^c   Colasanti, Marco ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b UNIVERSITY OF URBINO   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CONSTITUTIVE NITRIC OXIDE SYNTHASE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

CELL LEVEL; CELL TYPE; ENZYME ACTIVATION; ENZYME CROSS TALK; ENZYME SYNTHESIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ISOENZYMES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS);

EID: 33745814765     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2006.8.949     Document Type: Review

References (56)

1. Aliev G, Shi J, Perry G, Friedland RP, and Lamanna JC. Decreased constitutive nitric oxide synthase, but increased inducible nitric oxide synthase and endothelin-1 immunoreactivity in aortic endothelial cells of donryu rats on a cholesterol-enriched diet. Anat Rec 260: 16-25, 2000.
2. Aymerich MS, Bengoechea-Alonso MT, Lopez-Zabalza MJ, Santiago E, and Lopez-Moratalla N. Inducible nitric oxide synthase (iNOS) expression in human monocytes triggered by beta-endorphin through an increase in cAMP. Biochem Biophys Res Commun 245: 717-721, 1998.
3. Baltrons MA, Agullo L, and Garcia A. Dexamethasone up-regulates a constitutive nitric oxide synthase in cerebellar astrocytes but not in granule cells in culture. J Neurochem 64: 447-450, 1995.
4. Bedard S, Marcotte B, and Marette A. Insulin inhibits inducible nitric oxide synthase in skeletal muscle cells. Diabetologia 41: 1523-1527, 1998.
5. Bredt DS, Ferris CD, and Snyder SH. Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. J Biol Chem 267: 10976-10981, 1992.
6. Brune B and Lapetina EG. Phosphorylation of nitric oxide synthase by protein kinase A. Biochem Biophys Res Commun 181: 921-926, 1991.
7. 2+-dependent nitric-oxide synthase activity in human astrocytoma cells. J Biol Chem 272: 7582-7585, 1997.
8. Colasanti M and Persichini T. Nitric oxide: an inhibitor of NF-kappaB/Rel system in glial cells. Brain Res Bull 52: 155-161, 2000.
9. Colasanti M, Persichini T, Cavalieri E, Fabrizi C, Mariotto S, Menegazzi M, Lauro GM, and Suzuki H. Rapid inactivation of NOS-I by lipopolysaccharide plus interferon-gamma- induced tyrosine phosphorylation. J Biol Chem 274: 9915-9917, 1999.
10. Colasanti M, Persichini T, Menegazzi M, Mariotto S, Giordano E, Caldarera CM, Sogos V, Lauro GM, and Suzuki H. Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide. J Biol Chem 270: 26731-26733, 1995.
11. Colasanti M, Persichini T, Venturini G, Menegatti E, Lauro GM, and Ascenzi P. Effect of gabexate mesylate (FOY), a drug for serine proteinase-mediated diseases, on the nitric oxide pathway. Biochem Biophys Res Commun 246: 453-456, 1998.
12. Colasanti M, Persichini T, Venturini G, Polticelli F, and Musci G. Modulation of the nitric oxide pathway by copper in glial cells. Biochem Biophys Res Commun 275: 776-782, 2000.
13. Colasanti M and Suzuki H. The dual personality of NO. Trends Pharmacol Sci 21: 249-252, 2000.
14. Dawson TM, Steiner JP, Dawson VL, Dinerman JL, Uhl GR, and Snyder SH. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci USA 90: 9808-9812, 1993.
15. de laTorre JC and Stefano GB. Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res Brain Res Rev 34: 119-136, 2000.
16. Dinerman JL, Steiner JP, Dawson TM, Dawson V, and Snyder SH. Cyclic nucleotide dependent phosphorylation of neuronal nitric oxide synthase inhibits catalytic activity. Neuropharmacology 33: 1245-1251, 1994.
17. Gentile MT, Vecchione C, Maffei A, Aretini A, Marino G, Poulet R, Capobianco L, Selvetella G, and Lembo G. Mechanisms of soluble beta-amyloid impairment of endothelial function. J Biol Chem 279: 48135-48142, 2004.
18. Goldring CE, Narayanan R, Lagadec P, and Jeannin JF. Transcriptional inhibition of the inducible nitric oxide synthase gene by competitive binding of NF-kappa B/Rel proteins. Biochem Biophys Res Commun 209: 73-79, 1995.
19. Hopkins PN, Hunt SC, Schreiner PJ, Eckfeldt JH, Borecki IB, Ellison CR, Williams RR, and Siegmund KD. Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study. Atherosclerosis 141: 333-345, 1998.
20. Kanno S, Lee PC, Zhang Y, Ho C, Griffith BP, Shears LL, and Billiar TR. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase. Circulation 101: 2742-2748, 2000.
21. Katsuyama K, Shichiri M, Marumo F, and Hirata Y. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha. Arterioscler Thromb Vasc Biol 18: 1796-1802, 1998.
22. Kim HK, Cheon BS, Kim YH, Kim SY, and Kim HP. Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem Pharmacol 58: 759-765, 1999.
23. Komeima K, Hayashi Y, Naito Y, and Watanabe Y. Inhibition of neuronal nitric oxide synthase by calcium/calmodulin-dependent protein kinase IIalpha through Ser847 phosphorylation in NG108-15 neuronal cells. J Biol Chem 275: 28139-28143, 2000.
24. Koyanagi M, Egashira K, Kitamoto S, Ni W, Shimokawa H, Takeya M, Yoshimura T, and Takeshita A. Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis. Circulation 102: 2243-2248, 2000.
25. Kusano E, Akimoto T, Inoue M, Masunaga Y, Umino T, Ono S, Ando Y, Homma S, Muto S, Komatsu N, and Asano Y. Human recombinant erythropoietin inhibits interleukin-1 beta-stimulated nitric oxide and cyclic guanosine monophosphate production in cultured rat vascular smooth-muscle cells. Nephrol Dial Transplant 14: 597-603, 1999.
26. Law A, Gauthier S, and Quirion R. Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res Brain Res Rev 35: 73-96, 2001.
27. Leslie CC. Properties and regulation of cytosolic phospholipase A2. J Biol Chem 272: 16709-16712, 1997.
28. Lin HL and Murphy S. Regulation of astrocyte nitric oxide synthase type II expression by ATP and glutamate involves loss of transcription factor binding to DNA. J Neurochem 69: 612-616, 1997.
29. Mariotto S, Cuzzolin L, Adami A, Del Soldato P, Suzuki H, and Benoni G. Effect of a new non-steroidal anti-inflammatory drug, nitroflurbiprofen, on the expression of inducible nitric oxide synthase in rat neutrophils. Br J Pharmacol 115: 225-226, 1995.
30. Mariotto S, Cuzzolin L, Adami A, Del Soldato P, Suzuki H, and Benoni G. Inhibition by sodium nitroprusside of the expression of inducible nitric oxide synthase in rat neutrophils. Br J Pharmacol 114: 1105-1106, 1995.
31. Mariotto S, Menegazzi M, Carcereri dP, Cuzzolin L, Adami A, Suzuki H, and Benoni G. Protective effect of NO on gastric lesions and inhibition of expression of gastric inducible NOS by flurbiprofen and its nitro-derivative, nitroflurbiprofen. Br J Pharmacol 116: 1713-1714, 1995.
32. Mariotto S, Menegazzi M, and Suzuki H. Biochemical aspects of nitric oxide. Curr Pharm Des 10: 1627-1645, 2004.
33. Mariotto S, Miscusi M, Persichini T, Colasanti M, and Suzuki H: Ageing-related role of nitric oxide in the brain. In: The Neuroendocrine Immune Network in Ageing. (Straub RH and Mocchegiani E, eds). Elsevier, 2004, pp 291-300.
34. McCarty MF. Vascular nitric oxide, sex hormone replacement, and fish oil may help to prevent Alzheimer's disease by suppressing synthesis of acute phase cytokines. Med Hypotheses 53: 369-374, 1999.
35. Meurs H, Maarsingh H, and Zaagsma J. Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol Sci 24: 450-455, 2003.
36. Moncada S, Palmer RM, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
37. Moro MA, De Alba J, Leza JC, Lorenzo P, Fernandez AP, Bentura ML, Bosca L, Rodrigo J, and Lizasoain I. Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. Eur J Neurosci 10: 445-456, 1998.
38. Muniyappa R, Srinivas PR, Ram JL, Walsh MF, and Sowers JR. Calcium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells. Hypertension 31: 289-295, 1998.
39. Paine E, Palmantier R, Akiyama SK, Olden K, and Roberts JD. Arachidonic acid activates mitogen-activated protein (MAP) kinase-activated protein kinase 2 and mediates adhesion of a human breast carcinoma cell line to collagen type IV through a p38 MAP kinase-dependent pathway. J Biol Chem 275: 11284-11290, 2000.
40. Palomba L, Bianchi M, Persichini T, Magnani M, Colasanti M, and Cantoni O. Downregulation of nitric oxide formation by cytosolic phospholipase A2-released arachidonic acid. Free Radic Biol Med 36: 319-329, 2004.
41. Palomba L, Persichini T, Mazzone V, Colasanti M, and Cantoni O. Inhibition of nitric-oxide synthase-I (NOS-I)-dependent nitric oxide production by lipopolysaccharide plus interferon-gamma is mediated by arachidonic acid. Effects on NFkappaB activation and late inducible NOS expression. J Biol Chem 279: 29895-29901, 2004.
42. Park SK, Lin HL, and Murphy S. Nitric oxide limits transcriptional induction of nitric oxide synthase in CNS glial cells. Biochem Biophys Res Commun 201: 762-768, 1994.
43. Park SK, Lin HL, and Murphy S. Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-kappaB binding to DNA. Biochem J 322 (Pt 2): 609-613, 1997.
44. Peng HB, Spiecker M, and Liao JK. Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J Immunol 161: 1970-1976, 1998.
45. Sabatini DM, Lai MM, and Snyder SH. Neural roles of immunophilins and their ligands. Mol Neurobiol 15: 223-239, 1997.
46. Saito S, Foegh ML, Ramwell PW, and Koyanagi H. Estradiol effects on nitric oxide synthase expression in the rat aorta allograft. Transplant Proc 31: 2025-2027, 1999.
47. Schini VB, Catovsky S, Schray-Utz B, Busse R, and Vanhoutte PM. Insulin-like growth factor I inhibits induction of nitric oxide synthase in vascular smooth muscle cells. Circ Res 74: 24-32, 1994.
48. Stefano GB, Goumon Y, Bilfinger TV, Welters ID, and Cadet P. Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor. Prog Neurobiol 60: 513-530, 2000.
49. Syrbu SI, Waterman WH, Molski TF, Nagarkatti D, Hajjar JJ, and Sha'afi RI. Phosphorylation of cytosolic phospholipase A2 and the release of arachidonic acid in human neutrophils. J Immunol 162: 2334-2340, 1999.
50. Taylor BS, Kim YM, Wang Q, Shapiro RA, Billiar TR, and Geller DA. Nitric oxide down-regulates hepatocyte-inducible nitric oxide synthase gene expression. Arch Surg 132: 1177-1183, 1997.
51. Togashi H, Sasaki M, Frohman E, Taira E, Ratan RR, Dawson TM, and Dawson VL. Neuronal (type I) nitric oxide synthase regulates nuclear factor kappaB activity and immunologic (type II) nitric oxide synthase expression. Proc Natl Acad Sci USA 94: 2676-2680, 1997.
52. Venturini G, Colasanti M, Persichini T, Fioravanti E, Ascenzi P, Palomba L, Cantoni O, and Musci G. Beta-amyloid inhibits NOS activity by subtracting NADPH availability. FASEB J 16: 1970-1972, 2002.
53. Venturini G, Colasanti M, Persichini T, Fioravanti E, Federico R, and Ascenzi P. Selective inhibition of nitric oxide synthase type I by clonidine, an antihypertensive drug. Biochem Pharmacol 60: 539-544, 2000.
54. Visnjic D, Batinic D, and Banfic H. Arachidonic acid mediates interferon-gamma-induced sphingomyelin hydrolysis and monocytic marker expression in HL-60 cell line. Stood 89: 81-91, 1997.
55. Wang E, Spitzer JJ, and Chamulitrat W. Differential regulation of inducible nitric oxide synthase gene expression by ethanol in the human intestinal epithelial cell line DLD-1. Nitric Oxide 3: 244-253, 1999.
56. Yallampalli C and Dong YL. Estradiol-17beta inhibits nitric oxide synthase (NOS)-II and stimulates NOS-III gene expression in the rat uterus. Biol Reprod 63: 34-41, 2000.